With an investment of $70.00M in post-IPO equity on 18 April 2024, Korro Bio, Inc. has attracted funding from prominent investors including New Enterprise Associates, Atlas Venture, Deep Track Capital, Rock Springs Capital, Tri Locum Partners, and Blue Owl. The company operates in the biotechnology, health care, and pharmaceutical industries, positioning itself at the forefront of cutting-edge medical advancements. Korro Bio's mission is to rewrite the future for patients by repairing the underlying genetic causes of disease, signaling a promising trajectory for both the company and its potential to impact the future of medicine.
Korro Bio, Inc.
Edit the message. Rewrite the future. Pioneering RNA editing to deliver the future of medicine.
Founded 2018
Cambridge, United States
75 employees
IPO
Total: $479.50M
Biotechnology, Health Care +1
Cambridge, United States
75 employees
IPO
Total: $479.50M
Biotechnology, Health Care +1
General Information
Company Name
Korro Bio, Inc.
Founded Year
2018
Location
Cambridge, United States
Cambridge, United States
Employees
75
Industries
Biotechnology, Health Care, Pharmaceutical
Funding Stage
IPO
Social
BounceWatch is an independent company data service, not affiliated with Korro Bio, Inc.. To contact Korro Bio, Inc., visit korrobio.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Korro Bio, Inc. compare?
A PDF of Korro Bio, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Korro Bio, Inc. soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Korro Bio, Inc. on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About Korro Bio, Inc.
Business keywords: RNA editing, medicine, scientific insights, treatments, genetic editing, innovation, genetic therapy, biomedical research, precision medicine
Funding Rounds & Investors (8)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | $85.00M | 9 |
|
01 Mar 2026 |
| Private Placement VC | $70.00M | 6 |
|
01 Apr 2024 |
| Merger | $117.00M | 13 |
|
01 Nov 2023 |
| IPO | Undisclosed | - |
|
01 Jul 2023 |
| Series B | $116.00M | 15 |
|
01 Jan 2022 |
| Series A | $91.50M | 8 |
|
01 Sep 2020 |
| Spinout | Undisclosed | 2 |
|
01 Dec 2018 |
| Seed | Undisclosed | 2 |
|
01 Jan 2018 |
Korro Bio, Inc. Alternatives & Competitors
View All Alternatives
Korro Bio, Inc. vs
Tacit Therapeutics
United States
Tacit Therapeutics is creating RNA-targeting treatments for devastating diseases. By repurposing pre...
Venture round
13 employees
Biotechnology, Health Care
Korro Bio, Inc. vs
Rona Therapeutics
China
Empower Great People To Do Great Things
Series A
10 employees
Biotechnology, Health Care
Korro Bio, Inc. vs
Chimeron Bio
United States
Redefining genetic medicine with future-forward RNA technology designed to deliver meaningful patien...
Angel
12 employees
Biotechnology, Health Care
Amber Bio
Locanabio, Inc.
AIRNA
FAQ About Korro Bio, Inc.
Edit the message. Rewrite the future.
Pioneering RNA editing to deliver the future of medicine.
Korro Bio, Inc. was founded in 2018.
Korro Bio, Inc. is headquartered in Cambridge, United States.
Korro Bio, Inc. operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on RNA editing, medicine, scientific insights and treatments.
Korro Bio, Inc. has approximately 75 employees.
Korro Bio, Inc. has completed 8 funding rounds, raising a total of $479.50M. The latest funding stage is IPO.
Top alternatives and competitors to Korro Bio, Inc. include Tacit Therapeutics, Rona Therapeutics, Chimeron Bio, Amber Bio, Wave Life Sciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Korro Bio, Inc. and Tacit Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Korro Bio, Inc., https://bouncewatch.com/company/korro-bio-inc, updated 25 June 2026. When citing, please name BounceWatch and link this page.
